TOP STORIES

• BUSINESS Ajinomoto Builds Presence in ADC CDMO Business with Proprietary Technology
  January 27, 2026

• REGULATORY Japan Panel OKs AbbVie’s Aquipta, Ipsen’s Sohonos, and Novo’s IcoSema for Approval
  January 26, 2026

• BUSINESS Will Unlisted AGs Rush for June Listing or Be Left on Ice?
  January 23, 2026

• REGULATORY Japan’s 1st Xolair Biosimilar Likely from Celltrion as JAN Is Assigned
  January 23, 2026

• REGULATORY DPP Vows to Scrap Off-Year Drug Price Revisions in Election Platform
  January 23, 2026

• REGULATORY Japan Health Minister Says Early Call on FY2027 Off-Year Revision Improves Predictability
  January 22, 2026

• REGULATORY PMDA Chief Vows Stronger Support for Drug Discovery, Orphan Designations
  January 21, 2026

• ORGANIZATION OTC Industry Head Urges Caution on Extra Charges for “OTC-Like” Drugs
  January 20, 2026

• REGULATORY AMED, JPMA Poised to Embed Pharma Expertise in Drug Discovery
  January 20, 2026

• REGULATORY Japan’s Lower House Poll Set for Feb. 8 after Takaichi Calls Snap Vote
  January 20, 2026

• REGULATORY Bosulif, 4 Other Drugs Escape April Re-Pricing as “Spillover” Scrapped; Lixiana, Entresto Brace for Cuts
  January 19, 2026

• REGULATORY Expert Calls for Full Verification of CEA Guidelines and Analytical Frameworks
  January 16, 2026

• REGULATORY Japan Sets New Pricing Rules for Conditionally Approved Regenerative Medicines, Starting with Elevidys
  January 15, 2026

• BUSINESS Rohto to Roll Out 3- or 4-Day Workweek Option from April to Spur Growth, Retention
  January 15, 2026

• ORGANIZATION Pharma FTC Clarifies “Simple Beverages” under New Food Rules
  January 14, 2026

• REGULATORY Japan Panel to Review AbbVie’s Aquipta, Ipsen’s Sohonos on January 23
  January 13, 2026

• REGULATORY MHLW Pharma Director Says Uniform Drug Price Hike “Not Realistic,” Targeted Support Preferred
  January 9, 2026

• BUSINESS Bayer/Santen to Launch Eylea Bio-AG on February 2
  January 9, 2026

• BUSINESS Pharma Leaders Press for Drug Pricing Overhaul at New Year’s Confab
  January 8, 2026

• BUSINESS Generic Entry into DPP-4 Class Poised to Accelerate in 2026
  January 7, 2026

ページ

• « 先頭
• ‹ Prev
• …
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• …
• Next ›
• 最終 »